Lung Disease in Rheumatic Diseases
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA www.rheumatic.theclinics.com Consulting Editor MICHAEL H. WEISMAN May 2015 • Volume 41 • Number 2
Demystifying Lung Disease in the Rheumatic Diseases
Aryeh Fischer, MD, Editor Paul F. Dellaripa, MD, Editor This issue of Rheumatic Disease Clinics of North America is dedicated to Lung Disease in Rheumatic Diseases and aims to provide…
Lung Disease in Rheumatic Diseases
Michael H. Weisman, MD, Consulting Editor Aryeh and Paul have created a unique volume that should be a reference standard for years to come regarding disease description, pathogenesis, and treatment…
Psychosocial Aspects of Scleroderma
Patients with systemic sclerosis (SSc; also called scleroderma) have to cope with not only the physical impacts of the disease but also the emotional and social consequences of living with…
Musculoskeletal Manifestations of Systemic Sclerosis
Systemic sclerosis (SSc; scleroderma) is a chronic autoimmune connective tissue disease characterized by microvascular obliteration and sclerosis of the skin and internal organs. Although the clinical hallmark of the disease…
Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis
Pulmonary arterial hypertension (PAH) is one of the leading causes of death in patients with systemic sclerosis (SSc). Given the high prevalence and poor survival of SSc-PAH, and that aggressive…
Scleroderma Renal Crisis
Scleroderma renal crisis is a rare complication of systemic sclerosis (SSc) that remains severe. Prompt recognition and initiation of therapy with an angiotensin-converting-enzyme inhibitor offer the best chance to achieve…
Systemic Sclerosis
The gastrointestinal tract, affecting more than 90% of patients, is the internal organ most frequently involved in systemic sclerosis. Any part of the gastrointestinal tract can be affected, from the…
Management of Systemic-Sclerosis-Associated Interstitial Lung Disease
Although scleroderma-associated interstitial lung disease (SSc-ILD) is a significant contributor to both morbidity and mortality, its pathogenesis is largely unclear. Pulmonary function tests and high-resolution computed tomographic scanning continue to…
Management of Raynaud Phenomenon and Digital Ulcers in Scleroderma
Raynaud phenomenon (RP) and associated digital ischemia can be among the most vexing clinical problems for patients with systemic sclerosis (scleroderma). Understanding the treatment approach to RP and associated ischemia…
